
Public Safety versus Public Disclosure
When should there be restrictions on the dissemination of basic research results? This question has arisen in the context of papers from independent laboratories submitted to the journals Science and Nature.
When should there be restrictions on the dissemination of basic research results? This question has arisen in the context of papers from independent laboratories submitted to the journals Science and Nature. Ron Fouchier and colleagues from the Erasmus Medical Center in Rotterdam, the Netherlands and a team headed by Yoshihiro Kawaoka of the University of Wisconsin-Madison, were both studying the H5N1 strain of flu virus, which causes avian flu. Avian flu can decimate flocks of poultry, but is rarely transmissible to humans. Nevertheless, because of the close proximity in which humans and poultry reside, there is concern that the virus could someday acquire the ability to infect mammals, and become the source of a pandemic. Both laboratories, working independently, identified mutations in H5N1 that allowed mammal-to-mammal transmission, using ferrets as the experimental model.
In a rare response to those findings, the Department of Health and Human Services, acting on advice from The National Science Advisory Board for Biosecurity (NSABB) asked the authors of the papers and the editors of the journals to publish the papers in redacted form, where the conclusions would be published, but the methodology would not be made public. HHS also asked that language be added to the publications outlining the goals and potential health benefits of the research and detailing the safety measures taken to protect the laboratory workers and the public. In a
The authors agreed to the government’s request, and went a step further. In open letters published in Science and
Scientists are divided on whether redaction of the data is really in the public interest. Nonetheless, the willingness to pause for an open discussion about the risks versus benefits of this type of research will go some way towards balancing public safety with public health goals.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.


